Interpace Biosciences, Inc. (IDXG)
6.025
-0.36
(-5.71%)
USD |
OTCM |
Oct 02, 16:00
Interpace Biosciences Max Drawdown (5Y) : 96.07% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.07% |
| August 31, 2026 | 96.07% |
| July 31, 2026 | 96.07% |
| June 30, 2026 | 96.07% |
| May 31, 2026 | 96.07% |
| April 30, 2026 | 96.07% |
| March 31, 2026 | 96.07% |
| February 28, 2026 | 97.75% |
| January 31, 2026 | 97.78% |
| December 31, 2025 | 97.78% |
| November 30, 2025 | 97.78% |
| October 31, 2025 | 97.87% |
| September 30, 2025 | 98.37% |
| August 31, 2025 | 98.64% |
| July 31, 2025 | 98.64% |
| June 30, 2025 | 98.64% |
| May 31, 2025 | 98.64% |
| April 30, 2025 | 98.64% |
| March 31, 2025 | 98.64% |
| February 28, 2025 | 98.64% |
| January 31, 2025 | 98.64% |
| December 31, 2024 | 98.64% |
| November 30, 2024 | 98.64% |
| October 31, 2024 | 98.64% |
| September 30, 2024 | 98.64% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.64% |
| July 31, 2024 | 98.64% |
| June 30, 2024 | 98.64% |
| May 31, 2024 | 98.64% |
| April 30, 2024 | 98.64% |
| March 31, 2024 | 98.73% |
| February 29, 2024 | 98.73% |
| January 31, 2024 | 98.73% |
| December 31, 2023 | 98.73% |
| November 30, 2023 | 98.73% |
| October 31, 2023 | 98.73% |
| September 30, 2023 | 98.73% |
| August 31, 2023 | 98.73% |
| July 31, 2023 | 98.73% |
| June 30, 2023 | 98.73% |
| May 31, 2023 | 98.73% |
| April 30, 2023 | 98.73% |
| March 31, 2023 | 98.73% |
| February 28, 2023 | 98.73% |
| January 31, 2023 | 98.82% |
| December 31, 2022 | 98.82% |
| November 30, 2022 | 98.86% |
| October 31, 2022 | 98.86% |
| September 30, 2022 | 98.86% |
| August 31, 2022 | 98.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| PD-Rx Pharmaceuticals, Inc. | 100.0% |
| Medical Marijuana, Inc. | 99.94% |
| Acro Biomedical Co. Ltd. | 99.99% |
| Stella Diagnostics, Inc. | 99.58% |
| ZeroStack Corp. | 99.99% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.30 |
| Beta (5Y) | 0.6344 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 106.7% |
| Historical Sharpe Ratio (5Y) | -0.337 |
| Historical Sortino (5Y) | -0.7253 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.42% |